The DOI matches its Crossref record; 230 of the 230 references it cites were found in a registry or an index.
Investigating the crosstalk between chronic stress and immune cells: implications for enhanced cancer therapy
Open accessAbstract
Chronic stress has a substantial influence on the tumor microenvironment (TME), leading to compromised effectiveness of anti-cancer therapies through diverse mechanisms. It disrupts vital functions of immune cells that play a critical role in anti-tumor immunity, such as the inhibition of dendritic cells (DCs) and lymphocytes, while simultaneously enhancing the activity of immune cells that support tumor growth, such as myeloid-derived suppressor cells and tumor-associated macrophages. Furthermore, chronic stress exerts a significant impact on crucial mechanisms within the TME, including angiogenesis, DNA repair, hypoxia, extracellular matrix deposition, and tumor metabolism. These alterations in the TME, induced by stress, result from the activation of the hypothalamic–pituitary–adrenal axis and sympathetic nervous system, in conjunction with epigenetic modifications. In conclusion, chronic stress significantly influences the TME and impedes the efficacy of anti-cancer treatments, underscoring the importance of targeting stress pathways to improve therapeutic results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic stress disrupts the critical immune cell functions involved in anti-tumor immunity, inhibiting dendritic cells and lymphocytes, while enhancing the activity of tumor-supportive cells such as myeloid-derived suppressor cells and tumor-associated macrophages [65].”
From Comprehensive review of chronic stress pathways and the efficacy of behavioral stress reduction programs (BSRPs) in managing diseases. (2024) · cites this paper as [65]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–230 of 230
Yuan, L., Springer, J., Palus, S., Busquets, S., Jové, Q., de Lima, E. A., Anker, M. S., von Haehling, S., Ladrón, N. Á., Millman, O., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13116 · Cited by 20
Li, C., Cai, Q., Su, Z., Chen, Z., Cao, J., & Xu, F. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1149511 · Cited by 20
Cui, Y.-Z., Han, X.-Y., Liu, H.-T., Xie, Q., Guan, Y., Yin, B.-B., Xiao, J., Feng, D., Wang, X., Li, J.-W., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1081790 · Cited by 20
Self-citationOverexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients
Liu, Z., Zhang, W., Cheng, X., Wang, H., Bian, L., Wang, J., Han, Z., Wang, Y., Lian, X., Liu, B., et al. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00316-0 · Cited by 19
Self-citationFBXL2 promotes E47 protein instability to inhibit breast cancer stemness and paclitaxel resistance
Li, F., Niu, M., Qin, K., Guo, R., Yi, Y., Xu, J., Li, L., Xie, S., Fu, M., Wen, N., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02559-5 · Cited by 19
Rousseau, B., Murugan, S., Palagani, A., & Sarkar, D. K. (2022) · Breast Cancer Research · doi:10.1186/s13058-022-01526-y · Cited by 18
Li, W., Wan, J., Chen, C., Zhou, C., Liao, P., Hu, Q., Hu, J., Yang, W., Zhang, Y., Peng, C., et al. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02238-8 · Cited by 17
Silva, D., Kacprzak, K., Quintas, C., Gonçalves, J., & Fresco, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010767 · Cited by 17
Lou, F., Long, H., Luo, S., Liu, Y., Pu, J., Wang, H., Ji, P., & Jin, X. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114268 · Cited by 14
Aziz, F., Li, X., Chakraborty, A., Zheng, Y., Xin, M., Liu, K., & Dong, Z. (2022) · Gastric Cancer · doi:10.1007/s10120-022-01297-7 · Cited by 13
Effects of S‐pindolol in mouse pancreatic and lung cancer cachexia models
Springer, J., Jové, Q., de Lima, E. A., Ladrón, N. Á., López-Soriano, F. J., Busquets, S., Argilés, J. M. A., & Marks, D. L. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13249 · Cited by 13
Effects of Diet Quality and Psychosocial Stress on the Metabolic Profiles of Mice
Goto, T., Tomonaga, S., & Toyoda, A. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00859 · Cited by 12
β2‐adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma
Schuster, C., Akslen, L. A., & Straume, O. (2023) · Cancer Medicine · doi:10.1002/cam4.6424 · Cited by 11
Xie, J., Wang, X., Ge, H., Peng, F., Zheng, N., Wang, Q., & Tao, L. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28881 · Cited by 10
Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer
Mihalopoulos, M., Dovey, Z. S., Archer, M., Korn, T. G., Okhawere, K. E., Nkemdirim, W., Funchess, H., Rambhia, A., Mohamed, N., Kaplan, S. A., et al. (2020) · Cancers · doi:10.3390/cancers12092442 · Cited by 10
Association between Pre-Existing Sleep Disorders and Survival Rates of Patients with Breast Cancer
Chen, Y.-C., Chen, W., Chiang, M.-F., Shia, B., & Wu, S. (2022) · Cancers · doi:10.3390/cancers14030798 · Cited by 10
Zenga, J., Awan, M. J., Frei, A. C., Petrie, E., Sharma, G. P., Shreenivas, A. V., Shukla, M., & Himburg, H. A. (2022) · Head & Neck · doi:10.1002/hed.27028 · Cited by 10
Harjes, U. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.107 · Cited by 9
Blarigan, E. L. V., Ma, C., Ou, F., Bainter, T. M., Venook, A. P., Ng, K., Niedzwiecki, D., Giovannucci, E. L., Lenz, H., Polite, B. N., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34230 · Cited by 9
Suzuki, N., Niikura, R., Ihara, S., Hikiba, Y., Kinoshita, H., Higashishima, N., Hayakawa, Y., Yamada, A., Hirata, Y., Nakata, R., et al. (2019) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0288 · Cited by 8
Muqbil, I., Fatima, S., Azmi, A. S., Alsharidah, A. S., Khan, S. A., Aljaser, F., & Banu, N. (2020) · Medical Oncology · doi:10.1007/s12032-020-01422-5 · Cited by 8
Nagata, Y., Kawahara, T., Goto, T., Inoue, S., Teramoto, Y., Jiang, G., Fujimoto, N., & Miyamoto, H. (2020) · PubMed Central · Cited by 8
Harjes, U. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.115 · Cited by 7
Adrenergic-mediated increases in INHBA drive CAF phenotype and collagens
Nagaraja, A. S., Dood, R. L., Armaiz-Peña, G. N., Kang, Y., Wu, S. Y., Allen, J. K., Jennings, N. B., Mangala, L. S., Pradeep, S., Lyons, Y., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.149895 · Cited by 6
Self-citationXing, D., Li, L., Meng, D., Zhang, Y., & Ma, F. (2023) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-023-04412-1 · Cited by 5
A nervous disposition: the angiometabolic switch
Stone, L. (2017) · Nature Reviews Urology · doi:10.1038/nrurol.2017.200 · Cited by 4
Identification of HUHS190, a human naftopidil metabolite, as a novel anti-bladder cancer drug
Shimizu, T., Yamaguchi, K., Yamamoto, M., Kurioka, R., Kino, Y., Matsunaga, W., Nakao, S., Fukuhara, H., Tanaka, A., Gotoh, A., et al. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126744 · Cited by 4
Propranolol: What is BLOCKing Its Clinical Investigation in Breast Cancer?
Blaes, A. H., Domingo‐Musibay, E., & Kalinsky, K. M. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3818 · Cited by 4
Classification of Clear Cell Renal Cell Carcinoma based on Tumor Suppressor Genomic Profiling
Zhong, W., Zhang, F., Huang, C., Lin, Y., & Huang, J. (2021) · Journal of Cancer · doi:10.7150/jca.50462 · Cited by 4
Editorial: Cancer neuroscience: Drug repurposing targeting the innervated niche
Jin, M.-Z., Gao, X., & Jin, W. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1148706 · Cited by 2
Cited by
Sorted by citations
Immunology of stress: A review article
Alotiby, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216394 · Cited by 253
Shchaslyvyi, A. Y., Antonenko, S. V., & Telegeev, G. D. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21081077 · Cited by 73
Wang, L., Ge, J., Han, H., Jia, Y., & Qin, Y. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216986 · Cited by 50
Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies
Rozengurt, E., & Eibl, G. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02499-y · Cited by 49
Mitochondrial regulation in the tumor microenvironment: targeting mitochondria for immunotherapy
Ahn, M., Ali, A., & Seo, J. H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1453886 · Cited by 33
Metadata
- Authors
- Lei, Y., Liao, F., Tian, Y., Wang, Y., Xia, F., & Wang, J.
- Affiliations
- Army Medical University (CN)
- Chongqing University (CN)
- Corresponding author
- Xia, Feng
- Wang, JianHua
- ORCID
- Wang, JianHua
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2023-11-28
- Volume
- 17
- Pages
- 1321176-1321176
- ISSN
- 1662-453X (ISSN-L)
- PMC
- PMC10713832
- OpenAlex
- W4389095810
- Cited by
- 35
- References
- 230
- Citations by year
- 2026: 17 · 2025: 12 · 2024: 6
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Neuroscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (21827812)
- Centre Scientifique et Technique du Bâtiment
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- chronic stress, tumor microenvironment, antitumor immunity, dendritic cells, lymphocytes, myeloid-derived suppressor cells, tumor-associated macrophages, angiogenesis, DNA repair, hypoxia, extracellular matrix, cancer metabolism, hypothalamic-pituitary-adrenal axis, sympathetic nervous system, epigenetic modifications, cancer therapy resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review